Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 9/2008

01.09.2008 | Original Article

Sacral Chordoma: Can Local Recurrence After Sacrectomy Be Predicted?

verfasst von: S. A. Hanna, MRCS, W. J. S. Aston, FRCS (Orth), T. W. R. Briggs, MCh (Orth), FRCS, S. R. Cannon, MCh (Orth), FRCS, A. Saifuddin, MRCP, FRCR

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Surgical resection margins are reportedly the most important predictor of survival and local recurrence with sacral chordomas. We examined the relevance of invasion of the surrounding posterior pelvic musculature (piriformis and gluteus maximus) at initial diagnosis to local recurrence after sacrectomy. We retrospectively reviewed 18 patients with histologically verified sacral chordoma seen at our institution between 1998 and 2005. There were 14 men and four women with a mean age of 65.1 years (range, 31–78 years). The average overall followup was 4.4 years (range, 0.5–10 years), 5.4 years for the living patients (range, 3–10 years), and 2.8 years for the deceased (range, 0.5–5.4 years). Local recurrence occurred in 12 patients (66%) 29 months postoperatively (range, 2–84 months). Six of these patients had wide excisions at initial surgery, five had marginal excisions, and one had an intralesional excision. Ten patients had wide surgical margins, six of whom (60%) had local recurrences. Tumor invasion of adjacent muscles at presentation was present in 14 patients, 12 of whom (85%) had local recurrences. Sacroiliac joint involvement was seen in 10 patients, nine of whom (90%) had local recurrences. The findings suggest obtaining wide surgical margins posteriorly, by excising parts of the piriformis, gluteus maximus, and sacroiliac joints, may result in better local disease control in patients with sacral chordoma.
Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
Literatur
1.
Zurück zum Zitat Abdelwahab IF, Miller TT, Hermann G, Klein MJ, Kenan S, Lewis MM. Transarticular invasion of joints by bone tumors: hypothesis. Skeletal Radiol. 1991;20:279–283.PubMedCrossRef Abdelwahab IF, Miller TT, Hermann G, Klein MJ, Kenan S, Lewis MM. Transarticular invasion of joints by bone tumors: hypothesis. Skeletal Radiol. 1991;20:279–283.PubMedCrossRef
2.
Zurück zum Zitat Ariel IM, Verdu C. Chordoma: an analysis of twenty cases treated over a twenty-year span. J Surg Oncol. 1975;7:27–44.CrossRef Ariel IM, Verdu C. Chordoma: an analysis of twenty cases treated over a twenty-year span. J Surg Oncol. 1975;7:27–44.CrossRef
3.
Zurück zum Zitat Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol. 2003;10:291–296.PubMedCrossRef Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol. 2003;10:291–296.PubMedCrossRef
4.
Zurück zum Zitat Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom J. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88:2122–2134.PubMedCrossRef Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom J. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88:2122–2134.PubMedCrossRef
5.
Zurück zum Zitat Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN. Chordoma of the mobile spine: fifty years of experience. Spine. 2006;31:493–503.PubMedCrossRef Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, Chevalley F, Gasbarrini A, Picci P, Weinstein JN. Chordoma of the mobile spine: fifty years of experience. Spine. 2006;31:493–503.PubMedCrossRef
6.
Zurück zum Zitat Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Imatinib mesylate in chordoma. Cancer. 2004;101:2086–2097.PubMedCrossRef Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Imatinib mesylate in chordoma. Cancer. 2004;101:2086–2097.PubMedCrossRef
7.
Zurück zum Zitat Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol. 2007;19:367–370.PubMedCrossRef Casali PG, Stacchiotti S, Sangalli C, Olmi P, Gronchi A. Chordoma. Curr Opin Oncol. 2007;19:367–370.PubMedCrossRef
8.
Zurück zum Zitat Catton C, O’Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol. 1996;41:67–72.PubMed Catton C, O’Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol. 1996;41:67–72.PubMed
9.
Zurück zum Zitat Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma: prognostic factors and treatment. Spine. 1999; 24:1639–1645.PubMedCrossRef Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma: prognostic factors and treatment. Spine. 1999; 24:1639–1645.PubMedCrossRef
10.
11.
Zurück zum Zitat Dahlin DC, Unni KK. Bone Tumors. 4th Ed. Springfield, IL: Thomas; 1986:379–391. Dahlin DC, Unni KK. Bone Tumors. 4th Ed. Springfield, IL: Thomas; 1986:379–391.
12.
Zurück zum Zitat Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–120.PubMed Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–120.PubMed
13.
Zurück zum Zitat Eriksson B, Gunterberg B, Kindblom LG. Chordoma: a clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand. 1981;52:49–58.PubMed Eriksson B, Gunterberg B, Kindblom LG. Chordoma: a clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand. 1981;52:49–58.PubMed
14.
Zurück zum Zitat Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O’Fallon JR, Dozier JC, Piepgras DG. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg. 1993;78:741–747.PubMed Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O’Fallon JR, Dozier JC, Piepgras DG. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg. 1993;78:741–747.PubMed
15.
Zurück zum Zitat Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am. 2005;87:2211–2216.PubMedCrossRef Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am. 2005;87:2211–2216.PubMedCrossRef
16.
Zurück zum Zitat Gunterberg B, Romanus B, Sterner B. Pelvic strength after major amputation of the sacrum: an experimental study. Acta Orthop Scand. 1976;47:635–642.PubMed Gunterberg B, Romanus B, Sterner B. Pelvic strength after major amputation of the sacrum: an experimental study. Acta Orthop Scand. 1976;47:635–642.PubMed
17.
Zurück zum Zitat Hug EB, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, Rosenberg AE, Slater JM. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91:432–439.PubMed Hug EB, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, Rosenberg AE, Slater JM. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91:432–439.PubMed
18.
Zurück zum Zitat Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am. 2006;88:1532–1539.PubMedCrossRef Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am. 2006;88:1532–1539.PubMedCrossRef
19.
Zurück zum Zitat Husain F. Chordoma of the thoracic spine: report of a case. J Bone Joint Surg Br. 1960;42:560–564.PubMed Husain F. Chordoma of the thoracic spine: report of a case. J Bone Joint Surg Br. 1960;42:560–564.PubMed
20.
Zurück zum Zitat Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toyama Y. Local recurrence after S2-3 sacrectomy in sacral chordoma: report of four cases. J Neurosurg. 2002;97(1 suppl):98–101.PubMed Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toyama Y. Local recurrence after S2-3 sacrectomy in sacral chordoma: report of four cases. J Neurosurg. 2002;97(1 suppl):98–101.PubMed
21.
Zurück zum Zitat Kaiser T, Pritchard D, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984;53:2574–2578.PubMedCrossRef Kaiser T, Pritchard D, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984;53:2574–2578.PubMedCrossRef
22.
Zurück zum Zitat McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12:1–11.PubMedCrossRef McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12:1–11.PubMedCrossRef
23.
Zurück zum Zitat Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57–63.PubMedCrossRef Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57–63.PubMedCrossRef
24.
Zurück zum Zitat Osaka S, Kodoh O, Sugita H, Osaka E, Yoshida Y, Ryu J. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol. 2006;132:213–218.PubMedCrossRef Osaka S, Kodoh O, Sugita H, Osaka E, Yoshida Y, Ryu J. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol. 2006;132:213–218.PubMedCrossRef
25.
Zurück zum Zitat Rich TA, Schiller A, Suit HD, Mankin HJ. Clinical and pathological review of 48 cases of chordoma. Cancer. 1985;56:182–187.PubMedCrossRef Rich TA, Schiller A, Suit HD, Mankin HJ. Clinical and pathological review of 48 cases of chordoma. Cancer. 1985;56:182–187.PubMedCrossRef
26.
Zurück zum Zitat Saxton JP. Chordoma. Int J Radiat Oncol Biol Phys. 1981;7:913–915.PubMed Saxton JP. Chordoma. Int J Radiat Oncol Biol Phys. 1981;7:913–915.PubMed
27.
Zurück zum Zitat Soo MY. Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol. 2001;45:427–434.PubMedCrossRef Soo MY. Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol. 2001;45:427–434.PubMedCrossRef
28.
Zurück zum Zitat Sundaresan N, Huvos AG, Krol G, Lane JM, Brennan M. Surgical treatment of spinal chordomas. Arch Surg. 1987;122:1479–1482.PubMed Sundaresan N, Huvos AG, Krol G, Lane JM, Brennan M. Surgical treatment of spinal chordomas. Arch Surg. 1987;122:1479–1482.PubMed
29.
Zurück zum Zitat Volpe R, Mazabraud A. A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol. 1983;7:161–170.PubMedCrossRef Volpe R, Mazabraud A. A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm). Am J Surg Pathol. 1983;7:161–170.PubMedCrossRef
30.
Zurück zum Zitat Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA. Skull base chordomas: a review of 38 patients, 1958–1988. Br J Neurosurg. 1993;7:241–248.PubMedCrossRef Watkins L, Khudados ES, Kaleoglu M, Revesz T, Sacares P, Crockard HA. Skull base chordomas: a review of 38 patients, 1958–1988. Br J Neurosurg. 1993;7:241–248.PubMedCrossRef
31.
Zurück zum Zitat Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer. 1999;85:878–883.PubMedCrossRef Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer. 1999;85:878–883.PubMedCrossRef
32.
Zurück zum Zitat York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999;44:74–79; discussion 79–80.PubMedCrossRef York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery. 1999;44:74–79; discussion 79–80.PubMedCrossRef
Metadaten
Titel
Sacral Chordoma: Can Local Recurrence After Sacrectomy Be Predicted?
verfasst von
S. A. Hanna, MRCS
W. J. S. Aston, FRCS (Orth)
T. W. R. Briggs, MCh (Orth), FRCS
S. R. Cannon, MCh (Orth), FRCS
A. Saifuddin, MRCP, FRCR
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 9/2008
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-008-0356-7

Weitere Artikel der Ausgabe 9/2008

Clinical Orthopaedics and Related Research® 9/2008 Zur Ausgabe

Symposium: Molecular Genetics in Sarcoma

S100A6 Expression and Function in Human Osteosarcoma

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.